citrate de tri-magnésium nonahydraté, Ph.Eur., USP, 500 g, emballage plastique.

Ethyl 2-((4-fluorobenzyl)amino)-2-oxoacetate, 98%, 100g

3-Amino-3-(1-(tert-butoxycarbonyl)piperidin-3-yl)propanoic acid, 95%, 1g

ethyl 3-{[2-(1H-indol-3-yl)ethyl]amino}propanoate, 95.0%, 2g

6-Bromohexan-1-amine hydrobromide, 97%, 1g

4-[3-(Trifluoromethyl)phenyl]piperidin-4-ol hydrochloride, 97.0%, 100mg

5-[3,4-(Ethylenedioxy)phenyl]-5-oxovaleric acid, 95.0%, 1g

1-(4-Chloro-pyridin-2-yl)-ethanone, 95.0%, 1g

2-Phenylpyrimidine>98.0%(GC)200mg

tert-Butyl 5-Bromopyridin-2-ylcarbamate, 97.0%, 25g

3-[(2-nitro-4-sulfamoylphenyl)amino]propanoic acid, 97%, 250mg

TERT-BUTYL 4-((3,4-DICHLOROPHENOXY)METHYL)-4-HYDROXYPIPERIDINE-1-CARBOXYLATE, 90.0%, 250mg

2-(azidomethyl)naphthalene, 95.0%, 250mg